Gevo, Inc. (GEVO) Reaches $0.54 Yearly Low; Calyxt (CLXT) Sellers Increased By 22.37% Their Shorts

February 1, 2018 - By Louis Casey

The stock of Gevo, Inc. (NASDAQ:GEVO) hit a new 52-week low and has $0.51 target or 6.00% below today’s $0.54 share price. The 8 months bearish chart indicates high risk for the $10.77M company. The 1-year low was reported on Feb, 1 by If the $0.51 price target is reached, the company will be worth $646,440 less. The stock decreased 0.48% or $0.0026 during the last trading session, reaching $0.5424. About 231,078 shares traded. Gevo, Inc. (NASDAQ:GEVO) has declined 85.24% since February 1, 2017 and is downtrending. It has underperformed by 101.94% the S&P500.

Calyxt Incorporated (NASDAQ:CLXT) had an increase of 22.37% in short interest. CLXT’s SI was 791,100 shares in February as released by FINRA. Its up 22.37% from 646,500 shares previously. With 37,400 avg volume, 21 days are for Calyxt Incorporated (NASDAQ:CLXT)’s short sellers to cover CLXT’s short positions. The stock decreased 11.67% or $3.04 during the last trading session, reaching $23.01. About 50,119 shares traded. Calyxt, Inc. (NASDAQ:CLXT) has 0.00% since February 1, 2017 and is . It has underperformed by 16.70% the S&P500.

Among 3 analysts covering Calyxt Inc (NASDAQ:CLXT), 2 have Buy rating, 0 Sell and 1 Hold. Therefore 67% are positive. Calyxt Inc had 4 analyst reports since August 14, 2017 according to SRatingsIntel. The stock of Calyxt, Inc. (NASDAQ:CLXT) has “Buy” rating given on Tuesday, August 15 by Citigroup. The stock has “Hold” rating by Citigroup on Wednesday, September 27. The stock has “Buy” rating by Jefferies on Monday, August 14. Wells Fargo initiated the shares of CLXT in report on Monday, August 14 with “Buy” rating.

Calyxt, Inc., an agriculture biotechnology company, develops healthier specialty food ingredients and agricultural food crops using gene editing technology for plants. The company has market cap of $637.22 million. It engages in the development of high oleic soybeans, powdery mildew resistant wheat, cold storable potatoes, high fiber wheat, reduced browning potatoes, and herbicide tolerant wheat. It currently has negative earnings. The Firm was formerly known as Cellectis Plant Sciences, Inc. and changed its name to Calyxt, Inc. in May 2015.

Analysts await Gevo, Inc. (NASDAQ:GEVO) to report earnings on April, 4. They expect $-0.26 earnings per share, up 77.19% or $0.88 from last year’s $-1.14 per share. After $-0.36 actual earnings per share reported by Gevo, Inc. for the previous quarter, Wall Street now forecasts -27.78% EPS growth.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our daily email newsletter.

Free Email Newsletter

Enter your email address below to get the latest news and analysts' ratings for your stocks with our free daily email newsletter: